News

Mullen Automotive Investors: Join the Legal Action Today

Mullen Automotive Investors: Join the Legal Action Today

Mullen Automotive Investors: Join the Legal Action Today

In a significant move for investors of Mullen Automotive, the firm Faruqi & Faruqi, LLP is taking steps to address potential securities fraud affecting the company. For those who have incurred losses exceeding $75,000 in Mullen Automotive, the opportunity to become actively involved in this legal action is now available.

Understanding the Allegations Against Mullen Automotive

Mullen Automotive, Inc. (NASDAQ: MULN) is facing serious accusations as federal securities laws have allegedly been violated by the company and its executives. Reports suggest that the executives made misleading statements and omitted crucial details that affected investors' decisions.

Key Allegations Detailed

The complaint raises substantial concerns regarding the company’s operational integrity. It is claimed that:

  • Mullen’s leadership, including CEO David Michery, had no true intention of implementing a reverse stock split despite falsely representing otherwise.
  • Investors were misled about the legitimacy of business partnerships with companies like Rapid Response Defense Systems and Mullen Advanced Energy Operations, LLC.
  • The capability of their battery technology, frequently exaggerated, did not meet investor expectations.
  • Information about prior convictions of affiliated individuals, such as Lawrence Hardge, who has faced serious allegations, was not disclosed, further complicating the integrity of the company's public statements.
  • Overall, these misleading actions led to a dramatic decline in the stock price.

Impact of Misleading Information

Since the allegations first came to light, Mullen's stock price has dramatically fallen by over $3.25, reflecting a decrease of 96% and closing at around $0.015 per share. This sharp decline was influenced by the unusual trading volumes that raise red flags.

What Does Serving as Lead Plaintiff Mean?

In the class action lawsuit, the lead plaintiff is a nominated individual who has the most significant financial stake in the litigation. They act on behalf of the group of affected investors, ensuring that their collective voice is heard throughout the proceedings. Any member interested in stepping forward or learning more should seek counsel to discuss their participation.

Options for Investors

For those impacted, Faruqi & Faruqi encourages individuals who may possess details about Mullen's conduct to come forward. This includes former employees, shareholders, and anyone else who might have relevant information.

How to Get Involved?

Investors wishing to become involved in the class action are urged to reach out to the firm directly. Assistance is available through calling Faruqi & Faruqi partner Josh Wilson at 877-247-4292 or via additional inquiries at 212-983-9330 (Ext. 1310).

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP is a prominent national law firm specializing in securities litigation, with a successful track record of recovering substantial amounts for investors since its establishment in 1995. The firm operates from locations across the country, providing robust advocacy for investors' rights.

Frequently Asked Questions

What is the lawsuit against Mullen Automotive about?

The lawsuit addresses allegations of securities fraud, claiming misleading statements were made that deceived investors.

Who can become a lead plaintiff in this case?

The lead plaintiff is typically an investor who has suffered significant losses and has a typical profile among the affected investors.

What should I do if I believe I am affected?

If you believe your finances were negatively impacted by Mullen's actions, contact Faruqi & Faruqi for guidance on how to proceed.

Can I remain anonymous as a class member?

Yes, you can choose to remain an absent class member if you decide not to pursue the lead plaintiff role.

How can I get updates on this case?

Investors can sign up for updates through Faruqi & Faruqi’s contact channels, including their social media platforms.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 3

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 0

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Moves by ERES: Special Distribution and Future Plans

Updated Category News Views 196

Overview of ERES's Recent Strategic Dispositions ERES has recently concluded a significant transaction involving the sale of entities that own 1,446 residential suites in the Netherlands. This sale, which generated net proceeds of around €336 million, marks a pivotal step in the company's strategic realignment. In connection with this, ERES has reported the closure of...

Continue Reading
Innovative Cybersecurity Leaders Highlighted in 2025 Report

Updated Category News Views 274

Innovative Cybersecurity Leaders Unveiled for 2025 Eight trailblazing companies recognized for innovation and excellence in cybersecurity Enterprise Management Associates (EMA), a prominent IT research and consulting firm, has revealed its notable 2025 Vendor Vision Black Hat Edition. Created by seasoned security experts at EMA, the report highlights eight standout...

Continue Reading
Exosens Expands Night Vision Technology with Strategic NVLS Deal

Updated Category News Views 169

Exosens Expands Night Vision Technology with Strategic NVLS Deal Exosens, a leading company in high-tech imaging and detection technologies, is making waves in the defense industry by acquiring NVLS, a respected manufacturer and developer of night vision equipment. This strategic acquisition marks a significant step forward in enhancing Exosens’ capabilities and...

Continue Reading
Current Mortgage Trends: Insights from Freddie Mac's Latest Survey

Updated Category News Views 219

Latest Insights on Mortgage Rates Freddie Mac, a significant entity in the housing sector, has recently shed light on the current mortgage rate landscape in its latest report. The Primary Mortgage Market Survey, released recently, shows that the widely-used 30-year fixed-rate mortgage (FRM) has held steady at an average of 6.35 percent. This stable rate comes as the...

Continue Reading
Renasant Corporation and The First: Merger Milestone Achieved

Updated Category News Views 207

Renasant Corporation and The First Bancshares Completes Regulatory Approvals for Merger The recent merger approval marks a significant milestone for Renasant Corporation (NYSE: RNST) and The First Bancshares, Inc. Both companies are proud to announce that they have successfully received all necessary regulatory approvals to finalize their merger. This strategic move...

Continue Reading